Archives
I love to try to give back to the subscribers that continue to support the podcast and my mission to educate healthcare professionals about pharmacology. Today is a special day and I’m finally releasing the paperback version of my latest work that has taken over a year to develop! I’m giving it away for a cheap as […]
Read More
Osteoporosis is the condition in which bone density is reduced and the patient has an increased risk of fractures. According to the International Osteoporosis Foundation, an estimated 44 million people in the US population aged 50 and older suffer from osteoporosis and low bone mass. There are many risk factors such as age, alteration of […]
Read More
I’ve encountered numerous patients who are taking chronic, oral corticosteroids. We know that there are numerous potential adverse effects from long term corticosteroid use. Osteoporosis, cardiovascular risks, diabetes, and cataracts are a few of the potential complications from chronic use. Listen to more potential complications and adverse effects from corticosteroids here. Tapering corticosteroids can be […]
Read More
Sodium-glucose co-transporter 2 inhibitors (SGLT2s) are becoming popular treatments for type 2 diabetes mellitus. While typically classified as diabetes medications, there is more and more research coming out for their benefits in cardiovascular health and heart failure. There are currently four SGLT2s on the market, all still available as brand-name only: canagliflozin (Invokana), dapagliflozin (Farxiga), […]
Read More
Pulmonary toxicology involves the airways, lung parenchyma, mediastinum, pleura, pulmonary vasculature, and the neuromuscular system based on the route of exposure to the offending agent and the dose and duration of exposure. Acute pulmonary reactions are commonly manifested by fever, chills, cough, chest pain, dyspnea, pulmonary infiltration with consolidation or pleural effusion on x-ray, and […]
Read More